Navigation Links
Breast Cancer More Aggressive and Less Responsive to Treatment in Younger Women

A new study has found that tumor cell activity in women differs according to age, leading to a poorer prognosis of breast cancer in younger women.

Breast cancer tends to be more aggressive and less responsive to treatment in women under 50 as compared to older women, and the study may lead to targeted therapies that can help treat patients more effectively.

The study was conducted by a team of researchers led by Carey Anders at the Duke Institute for Genome Sciences & Policy and the Duke University Comprehensive Cancer Center.

As part of the study, researchers gathered information specific to premenopausal women by diagnosing more than 200,000 women with breast cancer in 2006, out of which about 22 percent were under the age of 50.

Researchers found that the tumors found in women under the age of 45 have certain patterns of cellular activity that confer a poorer prognosis in younger women, while the same tumor cell activity in older women confers a better prognosis, demonstrating the need for age-appropriate targeted therapies.

During the process by which cells change and become cancerous, we saw certain patterns in young womens tumors that we didnt see in the tumors found in women over the age of 45, Anders said.

If we are able to inhibit these processes by using drugs, some of which are already available and being used to treat other cancers, we might have a better chance at treating these women more effectively and possibly even curing them, Anders added.

Research is currently under way to determine what therapies might be effective in targeting the cellular activity in young womens tumors, with the hope of shutting it down and halting tumor growth.

The findings of the study were presented at the American Society of Clinical Oncology annual meeting in Chicago.


'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
(Date:11/21/2008)...nt and smoking cessation less likely among persons...D.H.D.) In a study of smokers with attention defi...d elevated hyperactivity and impulsivity, with or ... 8 weeks than those with inattention symptoms alon...dy, now available online in Nicotine and Tobacco ...
(Date:11/21/2008)...entions in computerized brain,training may help p...d fuller,lives, said Jeff Zimman, Chairman of Pos... at the annual Technology Innovators Conference in...nal Center for Technology Innovation to,promote i... Zimman said cognitive training programs can a...
(Date:11/21/2008)...ire/ -- The U.S. Department of Health and Human Se...Organizations (PSOs). , , The rule becomes...uirements and procedures for PSOs, new entities, w... work to collect, aggregate and analyze data - wit...confidentiality protections - to identify and redu...
(Date:11/21/2008)...VS Caremark today applauded the,Federal Trade Com...ddress,issues of competition and continued innova...gs. , "CVS Caremark serves millions of pati...rovide life-saving and life-enhancing treatments f...ion of a federal legislative pathway,for FDA appr...
Breaking Medicine News(10 mins):Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2Health News:New Applications for Cognitive Training 2Health News:Final Rule Issued for Patient Safety Organizations 2Health News:Final Rule Issued for Patient Safety Organizations 3Health News:CVS Caremark Applauds FTC's Leadership on Follow-on Biologics 2
...rs have identified a key receptor that could be a ...f acute respiratory distress syndrome (ARDS). //Th...tening condition. The receptor is similar to wha... taste (G-protein coupled receptors) There is no e...
...e Prime Minister Mr. Man Mohan Singh to take the i...he films and television. // With the ministries of...o reach consensus on modalities for implementing t...ter approached Prime Minister Manmohan Singh to re...
...be able to isolates molecule that would be helpful...volutionary study has been done independently by t...spital Boston and they have identified a master pr...change as a result of individual experiences. Sci...
...rnment on Wednesday for neglecting their duties ac... of Bihar Mr. Nitish Kumar gave the nod for the di...ried out with immediate effect. Last week, the go...edical officers and initiated departmental proceed...
Other Medicine News:
(Date:11/20/2008)...RY HILL, N.J., Nov. 20 New Jersey ...water advisory for its customers in the following...ounties: , , Middlesex County , , ,...x , Piscataway , South Plainfield ,..., Bound Brook , Bridgewater , ...
(Date:11/20/2008)...RSIDE, Calif., Nov. 20 Milk. It do... than originally thought. After years of,research...peptides found in,cow,s milk that stimulate the b... To view the Multimedia News Release, go to:, http..., While developing new cancer therapies, th...
(Date:11/20/2008)...YORK, Nov. 20 Clinical data from a...35th Annual Veith Symposium shows DVT,treatment w... Bacchus,Vascular, Inc. (Santa Clara, CA) success...n about 20 minutes. , This technique, calle...es,blood flow more quickly and safely than curren...
(Date:11/19/2008)...SAND OAKS, Calif., Nov. 19 /PRNewswire-FirstCall/ ...keda Oncology Company, a subsidiary of,Takeda Pha...ounced that,enrollment in the Phase 3 MONET1 tria...ith paclitaxel and carboplatin for the first-line ...(NSCLC) has been temporarily suspended,following ...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Former Navy Surgeon General Is Among Three New Accomplished TriWest Advisory Board Members 11434 1Former Navy Surgeon General Is Among Three New Accomplished TriWest Advisory Board Members 11434 2Former Navy Surgeon General Is Among Three New Accomplished TriWest Advisory Board Members 11434 3Tubbs Jones Announces Over 2436 Million in Construction Projects for Cleveland VA Hospital 11431 1Tennessee Tornadoes Spur Senior Move Managers to Aid Elderly in Crisis 11429 1Tennessee Tornadoes Spur Senior Move Managers to Aid Elderly in Crisis 11429 2Tennessee Tornadoes Spur Senior Move Managers to Aid Elderly in Crisis 11429 3Summit VetPharm Addressed Veterinarian Diverted Vectra 3D 28TM 29 3152 1Summit VetPharm Addressed Veterinarian Diverted Vectra 3D 28TM 29 3152 2Summit VetPharm Addressed Veterinarian Diverted Vectra 3D 28TM 29 3152 3
...nthly Implant and Phase IIa Daily,Oral Results, LA... Debiopharm,Group (Debiopharm), a global independe...ology and serious medical conditions,presented fi...ies,for the treatment of Alzheimer,s disease (AD) ...rence on the Prevention of Dementia,in Washington...
... the European Hematology,Association, SAN DIEGO, J...nc. , a biopharmaceutical company developing patie...ent of cancer, announced,interim data from a Phase...olent B-cell non-Hodgkin,s lymphoma (NHL). The dat...matology Association in,Vienna on Saturday. , "We ...
Other Medicine Technology:Clinical Update - Debio 9902 (ZT-1) for Alzheimer's Disease 2Clinical Update - Debio 9902 (ZT-1) for Alzheimer's Disease 3Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 2Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 3
...oved CNBT technology, which relieves the practitio...5 minutes. HOPE allows you the ability to mix medi...tion couldn't be easier, with a length of oxygen t...nebulizer into an inexpensive alternative to a tub...
...Vibrating Mesh Technology to efficiently deliver s...thma, COPD or other respiratory conditions. Patien...rying case that is easily transported wherever lif...e-top compressor nebulizer systems provides effect...
...tion nebulizer allows the clinician to deliver up ...side port for precise high flow mixtures into a pr...patients, delivers 8-12 lpm in the "primary input"... needs, DHD offers the P31000H, High Flow Closed D...
...t angles up to 45° without sacrificing medicat...es for a non-slip gripping surface, convenient leg...en tubing. The large diffuser and baffle plate ma...t concentration at every setting. High impact pla...
Medicine Products: